Risk factors for cardiovascular diseases and development of prehypertension

  • Vladimir V. Sherstnev P.K. Anokhin Research Institute of Normal Physiology, Moscow, Russia
  • Marina A. Gruden P.K. Anokhin Research Institute of Normal Physiology, Moscow, Russia http://orcid.org/0000-0001-6066-8908
  • V. P. Karlina Health and Medical Unit #170 of the Federal Medical and Biological Agency
  • V. M. Ryzhov Health and Medical Unit #170 of the Federal Medical and Biological Agency
  • A. V. Kuznetsova N.M. Emanuel Institute of Biochemical Physics
  • Robert D. Sewell Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, CF10 3NB, UK http://orcid.org/0000-0003-1702-5100
  • O. V. Senko A.A. Dorodnitsyn Computing Center, RAS of the Federal Research Center «Informatics and Management» of the RAS
Keywords: prehypertension, optimal blood pressure, risk factors for cardiovascular disease, dysregulation

Abstract

The aim of the study was to investigate the relationship between risk factors for cardiovascular disease and development of prehypertension. Methods. Comparative and correlation analyses of modifiable and non-modifiable risk factors for cardiovascular disease were performed in subjects aged 30—60 with «optimal» blood pressure (n = 63, BP <120/80 mm Hg) and prehypertension (n = 52, BP = 120—139 / 80—89 mm Hg). Results. The group with prehypertension compared with the «optimal» blood pressure group had significantly increased serum levels of low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol, sedentary/intellectual type of occupation, and significant combinations of risk factors. The risk factor combinations included an increased level of LDL cholesterol and a sedentary/intellectual occupation; increased serum levels of creatinine and triglycerides; hereditary burden of kidney disease and a sedentary/intellectual occupation; hereditary burden of diabetes mellitus and cardiac left ventricular hypotrophy. In subjects with prehypertension compared to subjects with «optimal» blood pressure, changes in correlations (correlation number, direction, and strength) between parameters of risk factors were documented. Conclusion. The features of interrelationships between risk factors for cardiovascular disease observed in prehypertension are considered a manifestation of early dysregulation pathology and disordered regulation of physiological systems, which maintain optimal blood pressure.

Downloads

Download data is not yet available.

References

1. Guo X., Zou L., Zhang X., Li J., Zheng L., Sun Z., Hu J., Wang NO., Suh Y. Prehypertention: a meta-analyses of the epidemiology, risk factors and prediction of progression. Tex Heart Ist. J. 2011; 38 (6): 643-52.
2. Erina AM, Rotar OP, Orlov AV, Sainzev VN, Shalnova SA Deev AD et al. Prehypertension and cardiometabolic risk factors (based on the data of the ESSE-RF study). Arterialnaya gipertenziya. 2017; 23 (3): 243-52. (in Russian)
3. Mainous AG 3rd, Everett CJ, Liszka H, King DE, Egan BM. rehypertension and mortality in a nationally representative cohort. Am J Cardiol. 2004; 94(12): 1496-500.
4. Gu Q., Chen H., Xiufang D., Dahiel W.J., Jian-feng H., et al.Prehypertension and risk of cardiovascular disease in Chinese adults. J. Hypertens. 2009; 27 (4): 721-29.
5. Ishikawa Y, Ishikawa J, Ishikawa S, Kajii E, Schwartz JE, Pickering TG, Kario K; Prehypertension and the risk for cardiovascular disease in the Japanese general population: the Jichi Medical School Cohort Study. Jichi Medical School Cohort Investigators Group. J Hypertens. 2010; 28 (8): 1630-37.
6. Huang Y, Wang S, Cai X, Mai W, Hu Y, Tang H, Xu D. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 2013; 2: 11-177.
7. Huang Y, Su L, Cai X, Mai W, Wang S, Hu Y, Wu Y, Tang H, Xu D. Association of all-cause and cardiovascular mortality with prehypertension: a meta-analysis. Am Heart J. 2014 ; 167(2): 160-8.
8. Fomin IV, Badin Yu.V., Polyakov DS, Belyakov Yu.N., Mareyev V.Yu. Ageev F.T. et al. Prehypertension: how often this sosony of the cardiovascular system is common in the citizens of the European part of Russia (Evidence from EPOCHA-AG2002-2007). Klinicheskaya meditsina. 2013; 5(2): 38-46. (in Russian)
9. Zhang W, Li N. Prevalence, risk factors, and management of prehypertension. Int J Hypertens. 2011; 2011: 605359.
10. Wang R, Lu X, Hu Y, You T. Prevalence of prehypertension and associated risk factors among health check-up population in Guangzhou, China. Int J Clin Exp Med. 2015; 8(9): 16424-33.
11. Diagnosis and treatment of arterial hypertension (clinical recommendations). Kardiologicheskiy vestnik. 2015; 10(1): 5-30. (in Russian)
12. Kuznetsova AV, Kostomarova IV, Senko O.V. Logico-statistical analysis of the relationship between clinical and laboratory indicators with the occurrence of cerebral circulation disorders in elderly patients with chronic cerebral ischemia. Mathematicheskaya Biologiya i Bioinformatika. 2013; 8(1): 182-224. (in Russian)
13. Xu T, Liu J, Zhu G, Liu J, Han S. Prevalence of prehypertension and associated risk factors among Chinese adults from a large-scale multi-ethnic population survey. BMC Public Health. 2016; 16(1): 775.
14. Kryzhanovskiy G.N. Disregulatory pathology. In: Disregulatory pathology. A guide for doctors and biologists. [Disregulyatornaya patologiya. Rukovodstvo dlya vrachey I biologov]. Ed. G. N. Kryzhanovskiy. Moscow; Meditsina. 2002; 18-78. (in Russian)
15. Sudakov K.V. Information communication of the functional systems of the body in normal and with emotional stress. In the book. Disregulatory pathology. A guide for doctors and biologists. [Disregulatornaya patologiya. Rukovodstvo dlya vrachey I biologov]. Ed. G.N. Kryzhanovskiy. Moscow; Meditsina 2002 ; 176-87. (in Russian)
16. Elliott WJ, Black HR. Prehypertension. Nat Clin Pract Cardiovasc Med. 2007; 4(10): 538-48.
Published
2018-10-05
How to Cite
Sherstnev V. V., Gruden M. A., Karlina V. P., Ryzhov V. M., Kuznetsova A. V., Sewell R. D., Senko O. V. Risk factors for cardiovascular diseases and development of prehypertension // Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya (Pathological physiology and experimental therapy). 2018. VOL. 62. № 3. PP. 37–43.
Section
Original research

Most read articles by the same author(s)